Clinical Trial Update: Influence of Prior Chemotherapy on Clinical Benefit With Erlotinib in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer With or Without EGFR Gene Mutation [Phase 2]

View source ↗

Summary

Phase 2 study examining whether prior chemotherapy changes the clinical benefit of erlotinib in patients with advanced non-squamous non-small cell lung cancer, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tarceva (erlotinib)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Advanced Non-Squamous Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED